Fusion Genomics Establishes Wastewater Surveillance Pilot Study at Toronto Airport
Fusion Genomics has established a fully automated, infectious-disease surveillance facility at Toronto Pearson International Airport.
Read MorePosted by Andy Lundin | Jan 12, 2023 | Covid 19 |
Fusion Genomics has established a fully automated, infectious-disease surveillance facility at Toronto Pearson International Airport.
Read MorePosted by Andy Lundin | Jan 12, 2023 | Company News, Diagnostic Technologies |
Helix announced a global strategic partnership with QIAGEN N.V. to jointly develop companion diagnostics for hereditary diseases.
Read MorePosted by Chris Wolski | Jan 9, 2023 | Molecular Diagnostic Analyzers |
PathogenDx’s involvement with Operation Warp Speed, demonstrated the efficacy of microarray technology for diagnostic testing.
Read MorePosted by Chris Wolski | Jan 5, 2023 | Middleware & Software |
These findings give labs a blueprint for using data analytics to ensure patient access to testing during future infectious disease outbreaks.
Read MorePosted by Chris Wolski | Jan 5, 2023 | Cervical (HPV) |
The triage approach offers women and labs a more efficient and effective way to diagnose and manage cervical cancer earlier.
Read More